AFP and neoplasm: Diagnosis starts with identifying its clinical features and associating it with age-related malignancy in this population and the use of tumor-associated markers (CA-125, CA 19-E4, CEA, alpha-fetoprotein (AFP), Inhibin, and PSA) for the culprit underlying malignancy.